Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Mar 2014 GlobalData Lymphoma132 Pages Price :
$ 2500
Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2014\" provides data on the Cutaneous B-Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cutaneous B-Cell Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cutaneous B-Cell Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cutaneous B-Cell Lymphoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Cutaneous B-Cell Lymphoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Cutaneous B-Cell Lymphoma 18
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Transgene SA 25
Clinical Trial Overview of Transgene SA 25
Incyte Corporation 26
Clinical Trial Overview of Incyte Corporation 26
Clinical Trial Overview of Top Institutes / Government 27
Fred Hutchinson Cancer Research Center 27
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 27
National Cancer Institute 28
Clinical Trial Overview of National Cancer Institute 28
Peter MacCallum Cancer Centre 29
Clinical Trial Overview of Peter MacCallum Cancer Centre 29
Wake Forest University 30
Clinical Trial Overview of Wake Forest University 30
Northwestern University 31
Clinical Trial Overview of Northwestern University 31
University Hospital, Bordeaux 32
Clinical Trial Overview of University Hospital, Bordeaux 32
Case Comprehensive Cancer Center 33
Clinical Trial Overview of Case Comprehensive Cancer Center 33
University of Washington 34
Clinical Trial Overview of University of Washington 34
Stanford University 35
Clinical Trial Overview of Stanford University 35
Five Key Clinical Profiles 36

Appendix 129
Abbreviations 129
Definitions 129
Research Methodology 130
Secondary Research 130
About GlobalData 131
Contact Us 131
Disclaimer 131
Source 132

List of Table


Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Cutaneous B-Cell Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Cutaneous B-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Cutaneous B-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Cutaneous B-Cell Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2014* 18
Cutaneous B-Cell Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Cutaneous B-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Transgene SA, 2014* 25
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2014* 26
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 27
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 28
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Peter MacCallum Cancer Centre, 2014* 29
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 30
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 31
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 32
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 33
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 34
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 35

List of Chart


Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Cutaneous B-Cell Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Cutaneous B-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Cutaneous B-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Cutaneous B-Cell Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Cutaneous B-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Cutaneous B-Cell Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 130

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 2500
$ 5000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top